Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator's Choice in particpants with FL

A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator’s Choice in Participants with Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)

Disease Types: Lymphoma

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs InvestigatorÂ’s Choice in Participants with Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)

For More Information:

https://clinicaltrials.gov/study/NCT06911502?term=Golcadomide%20in%20combination%20with%20Rituximab%20in%20Follicular%20Lymphoma&rank=3